BNB Plus Corp. (OTCQB: BNBX) ("BNB Plus" or the "Company") today announced that, in furtherance of its ongoing strategic review, it has reached a mutual agreement with Cypress Management, LLC and its affiliates...
BNB Plus Corp. (Nasdaq: BNBX) ("BNB Plus" or the "Company") today announced that it has received a delisting determination from the Hearing Panel of the Nasdaq Stock Market LLC ("Nasdaq") as a result of...
Silvermine Capital Leads New and Existing Investor Group in Partnership with GlobalStake to Support Strategic Review of Digital Asset and Biotechnology Businesses Additional...
BNB Plus Corp. (Nasdaq: BNBX) ("BNB Plus" or the "Company"), today announced that its biopharmaceutical subsidiary, LineaRx, Inc. ("LineaRx"), has successfully completed production of its largest order...
Company Treasury Exceeds $12 Million with Recently Implemented Active Yield Generation Strategy Provides Nasdaq Listing Status Update
Patent Covers the Composition of LineaRx's Proprietary Linea™ RNA Polymerase (RNAP), a Core Technology Empowering the Linea™ IVT Platform
Provides Updated on BNB Token Holdings and Operating Company Performance
ORLANDO, FLORIDA / ACCESS Newswire / February 6, 2026 / RedChip Companies will air interviews with OBOOK Holdings Inc. (NASDAQ:OWLS) ("OwlTing") and BNB Plus Corp. (Nasdaq:BNBX) on the RedChip Small Stocks,...